{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The woman, who is not an Irish citizen, sought an abortion under a clause in the new Protection of Life During Pregnancy Act, saying that she was suicidal.", "headline": {"main": "Case in Which Abortion Was Denied Reignites Controversy Over Irish Law", "print_headline": "Case in Which Abortion Was Denied Reignites Controversy Over Irish Law"}, "abstract": "Woman living in Ireland who was refused abortion despite asserting that she was suicidal delivers her baby by cesarean; Irish Parliament legalized termination of pregnancy in July 2013 in cases when there is real and substantial risk to life of mother, including threat of suicide over pregnancy; psychiatrists determined that woman had suicidal thoughts, but obstetrician declared that fetus was viable and that it should be delivered; baby is reported to be healthy and is expected to be taken into state care.", "print_page": "6", "word_count": "866", "_id": "53f1469d7988100a0203743d", "snippet": "The woman, who is not an Irish citizen, sought an abortion under a clause in the new Protection of Life During Pregnancy Act, saying that she was suicidal.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/18/world/europe/case-in-which-abortion-was-denied-reignites-controversy-over-irish-law.html", "multimedia": [], "subsection_name": "Europe", "keywords": [{"value": "Ireland", "is_major": "Y", "rank": "1", "name": "glocations"}, {"value": "Abortion", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Law and Legislation", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Women and Girls", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Halappanavar, Savita", "is_major": "N", "rank": "5", "name": "persons"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Douglas", "lastname": "DALBY"}], "original": "By DOUGLAS DALBY"}, "document_type": "article", "pub_date": "2014-08-18T00:00:00Z", "section_name": "World"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "Alarmed by a rapid increase in spending on compounded drugs, like a $1,600 baby balm, insurers and others are acting to control their use.", "headline": {"main": "Pharmacies Turn Drugs Into Profits, Pitting Insurers vs. Compounders", "print_headline": "In the Alchemist\u2019s Lab"}, "abstract": "Health insurers, unnerved by flurry of spending on compounded drugs, are moving to curb their use by discontinuing coverage of myriad ingredients used in compounding.", "print_page": "1", "word_count": "1241", "_id": "53ed56607988104a4d54556d", "snippet": "Alarmed by a rapid increase in spending on compounded drugs, like a $1,600 baby balm, insurers and others are acting to control their use.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2014/08/15/business/pharmacies-turn-drugs-into-profits-pitting-insurers-vs-compounders.html", "multimedia": [{"subtype": "wide", "url": "images/2014/08/15/business/PHARMA/PHARMA-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2014/08/15/business/PHARMA/PHARMA-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2014/08/15/business/PHARMA/PHARMA-articleLarge.jpg", "height": 559, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2014/08/15/business/PHARMA/PHARMA-articleLarge.jpg", "xlargeheight": "559"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2014/08/15/business/PHARMA/PHARMA-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2014/08/15/business/PHARMA/PHARMA-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Health Insurance and Managed Care", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Ahmed, Kareem", "is_major": "N", "rank": "4", "name": "persons"}, {"value": "Landmark Medical Management", "is_major": "N", "rank": "5", "name": "organizations"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2014-08-15T00:00:00Z", "section_name": "Business Day"}], "meta": {"hits": 2, "offset": 0, "time": 62}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}